By Peter A. McCullough, MD, MPH
We often remember events from our childhood that came from physical experiences such as a broken arm or falling into a stream. Most patients from yesteryear remember childhood rheumatic or scarlet fever. Parents bringing their children age 5-11 years for COVID-19 vaccination may be creating adverse childhood experiences based on the most recent CDC safety data published by Hause et al in MMWR.
Moderna, which had greater frequency of adverse events than Pfizer, for example, caused 30% of children to have fever and vomit. Combined, 22% reported that boosters had a negative health impact, 14% could not perform daily activities to return to school, and 2% were so sick they required acute medical care. Adverse childhood experiences can have lasting social and psychological ramifications later in life, particularly if they are repeated. No vaccine, no matter how theoretically compelling, should be in public use with these symptomatic side effects. Vaccines should have acceptable safety profiles with <5% having any significant short-term symptoms, be safe over the long term, provide at least 50% protection against a disease, inhibit transmission, and last at least a year. Faulty vaccines that underperform or make our kids sick should be rejected by parents and removed from the market to protect public safety.
If you find “Courageous Discourse” enjoyable and useful to your endeavors, please subscribe as a paying or founder member to support our efforts in helping you engage in these discussions with family, friends, and your extended circles.
Hause AM, Marquez P, Zhang B, Su JR, Myers TR, Gee J, Panchanathan SS, Thompson D, Shimabukuro TT, Shay DK. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years – United States, October 12-January 1, 2023. MMWR Morb Mortal Wkly Rep. 2023 Jan 13;72(2):39-43. doi: 10.15585/mmwr.mm7202a5. PMID: 36634021.
O’Shea BQ, Demakakos P, Cadar D, Kobayashi LC. Adverse Childhood Experiences and Rate of Memory Decline From Mid to Later Life: Evidence From the English Longitudinal Study of Ageing. Am J Epidemiol. 2021 Jul 1;190(7):1294-1305. doi: 10.1093/aje/kwab019. PMID: 33534903; PMCID: PMC8484774.